|
[Related PubMed/MEDLINE]
Total Number of Papers: 170
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies. |
BCC, HSCORE, LINE-1, L1, MM, SCC, TMA |
| 2 |
2020 |
A Current Review on Drug Loaded Nanofibers: Interesting and Valuable Platform for Skin Cancer Treatment. |
BCCs, SCCs |
| 3 |
2020 |
CO2 laser ablative fractional resurfacing photodynamic therapy for actinic keratosis and nonmelanoma skin cancer: a randomized split-side study. |
AFR, AKs, ALA, PDT |
| 4 |
2020 |
De novo sequence assembly requires bioinformatic checking of chimeric sequences. |
HPV |
| 5 |
2020 |
Delayed Reconstruction with Full-Thickness Skin Grafts Following Defect Size Reduction in Head and Neck Nonmelanoma Skin Cancer. |
--- |
| 6 |
2020 |
Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer. |
BCC, DLQI, SCC |
| 7 |
2020 |
Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy. |
BCC, CSCC, MCC |
| 8 |
2020 |
Insulin-like Growth Factor-1 Impacts p53 Target Gene Induction in UVB-irradiated Keratinocytes and Human Skin. |
IGF-1, pol eta, UVB |
| 9 |
2020 |
Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study. |
CI, HRs |
| 10 |
2020 |
Non-Melanoma Skin Cancers: Biological and Clinical Features. |
BCC, MCC, SCC |
| 11 |
2020 |
Nonmelanoma Skin Cancers: Embryologically Relevant Sites and UV Exposure. |
BCCs, ERS |
| 12 |
2020 |
Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review. |
PD-1, PD-L1 |
| 13 |
2020 |
Protective Effects of Dietary Grape on UVB-Mediated Cutaneous Damages and Skin Tumorigenesis in SKH-1 Mice. |
GP |
| 14 |
2020 |
Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis. |
BCCs, MMS |
| 15 |
2020 |
Significance of SOX18 expression in nonmelanoma skin cancers for prediction of high-risk patients: a preliminary study. |
BCC, SCC, SK |
| 16 |
2020 |
Silibinin and non-melanoma skin cancers. |
US, UVB |
| 17 |
2020 |
The sirtuin 6: An overture in skin cancer. |
BCC, SCC |
| 18 |
2020 |
The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer. |
QOL, SCI |
| 19 |
2020 |
Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer. |
PROMs, QOL, SCQOLIT |
| 20 |
2019 |
A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location. |
MMS |
| 21 |
2019 |
An update on topical photodynamic therapy for clinical dermatologists. |
AK, PDT |
| 22 |
2019 |
Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma). |
--- |
| 23 |
2019 |
Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids. |
SRT |
| 24 |
2019 |
DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice. |
UA, UV |
| 25 |
2019 |
Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review. |
MMS |
| 26 |
2019 |
Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant Recipients. |
KTRs |
| 27 |
2019 |
Incidence of Malignancies in Patients Treated With Sirolimus Following HeartTransplantation. |
CI, CNI, HR, HT, IS, non-NMSC, PTLD, SRL |
| 28 |
2019 |
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI). |
BCC, DLQI, HRQoL |
| 29 |
2019 |
Nicotinamide N-methyltransferase in nonmelanoma skin cancers. |
BCC, NNMT, SCC |
| 30 |
2019 |
Optimal cosmetic outcomes for basal cell carcinoma: a retrospective study of nonablative laser management. |
BCCs, MMS, OCT, PDL, RCM |
| 31 |
2019 |
Peri-operative delineation of non-melanoma skin cancer margins invivo with handheld reflectance confocal microscopy and video-mosaicking. |
MMS, RCM |
| 32 |
2019 |
Quantity and characteristics of flap or graft repairs for skin cancer on the nose or ears: a comparison between Mohs micrographic surgery and plastic surgery. |
MMS |
| 33 |
2019 |
Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies. |
AEs, MACEs, PYs, SAEs, SIs |
| 34 |
2019 |
Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy. |
EAR, SIR |
| 35 |
2019 |
Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma. |
BCC, BMP-2, Ptch, UVB |
| 36 |
2019 |
Skin cancer knowledge and photoprotective practices of organ transplant recipients. |
OTRs, UVR |
| 37 |
2019 |
Skin Cancer: Squamous and Basal Cell Carcinomas. |
BCC, SCCs |
| 38 |
2019 |
The Prognostic Value of Podoplanin Expression in Nonmelanoma Skin Cancers: Correlation With Lymphatic Vessel Density. |
BCC, BSC, SCC, SK |
| 39 |
2019 |
Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer. |
BCC, cSCC, EMPD, MCC, PD-1 |
| 40 |
2019 |
UV exposure, preventive habits, risk perception, and occupation in NMSC patients: A case-control study in Trieste (NE Italy). |
--- |
| 41 |
2019 |
UVB drives different stages of epigenome alterations during progression of skin cancer. |
IPA, UVB |
| 42 |
2018 |
A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma. |
cSCC |
| 43 |
2018 |
Collagen disruption as a marker for basal cell carcinoma in presurgical margin detection. |
OPI |
| 44 |
2018 |
Cryosurgery + 5% 5-Fluorouracil for Treatment of Superficial Basal Cell Carcinoma and Bowen's Disease [Formula: see text]. |
sBCC, SCCIS |
| 45 |
2018 |
Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute. |
BCC, MM, NB-UVB, SCC |
| 46 |
2018 |
Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling. |
GLSE, Hh |
| 47 |
2018 |
Immune consequences induced by photodynamic therapy in non-melanoma skin cancers: a review. |
PDT |
| 48 |
2018 |
Mohs micrographic surgery for digital melanoma and nonmelanoma skin cancers. |
MMS |
| 49 |
2018 |
Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan. |
CAS, EMPD, SCC |
| 50 |
2018 |
Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers. |
AK, BCC, SCC |
| 51 |
2018 |
Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature. |
IBD |
| 52 |
2018 |
Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients. |
LTRs |
| 53 |
2018 |
The economic burden of occupational non-melanoma skin cancer due to solar radiation. |
BCC, HRQoL, OOPCs, SCC, UV |
| 54 |
2018 |
The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines. |
IBD, NZ |
| 55 |
2018 |
Utilization of Topographical Mohs Micrographic Surgery Maps for Rapid Review of Clinicopathologic Characteristics of Nonmelanoma Skin Cancers of the Ear. |
BCCs, MMS, SCCs |
| 56 |
2017 |
Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers. |
BCC, cSCC, MCC, MMs |
| 57 |
2017 |
Daylight photodynamic therapy vs. Conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra-individual comparison study. |
AK, C-PDT, DL-PDT |
| 58 |
2017 |
Does ultrasound measurement improve the accuracy of electronic brachytherapy in the treatment of superficial non-melanomatous skin cancer? |
EBT, US |
| 59 |
2017 |
Long-Lived Epidermal Cancer-Initiating Cells. |
CICs |
| 60 |
2017 |
Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response. |
beta-HPVs |
| 61 |
2017 |
Malignancy and Janus Kinase Inhibition. |
RA |
| 62 |
2017 |
Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. |
AKs, ATP |
| 63 |
2017 |
Rapid visualization of nonmelanoma skin cancer. |
--- |
| 64 |
2017 |
Skull Base Invasion Patterns and Survival Outcomes of Nonmelanoma Skin Cancers. |
BCC, CN, DSS, OS |
| 65 |
2017 |
Surgical Treatment with Locoregional Flap for the Nose. |
--- |
| 66 |
2017 |
The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients. |
CNIs |
| 67 |
2017 |
The feasibility of using ultrasound during follow-up for superficial non-melanoma skin cancers after electronic brachytherapy. |
EBT, US |
| 68 |
2017 |
Unnecessary Cost of Post-Mohs Permanent Pathology. |
MMS |
| 69 |
2017 |
Updates on the Management of Non-Melanoma Skin Cancer (NMSC). |
BCCs, NMSC, SCCs |
| 70 |
2016 |
Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas. |
BCC, EGFR, SCC |
| 71 |
2016 |
Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. |
BCC, SCC |
| 72 |
2016 |
Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients. |
HIV, IC, IS, NMSC-ASE, SOTRs |
| 73 |
2016 |
Peritumoral inflammatory reaction in non-melanoma skin cancers - histological and immunohistochemical study. |
BCCs, SCCs |
| 74 |
2016 |
Prevalence and Clinical Characteristics of Nonmelanoma Skin Cancers Among Hispanic and Asian Patients Compared With White Patients in the United States: A 5-Year, Single-Institution Retrospective Review. |
--- |
| 75 |
2016 |
Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers. |
AK, BCC, IW, OW, SCC, SR, UV |
| 76 |
2016 |
Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study. |
AR, CI, HR, MI, SM, VTE |
| 77 |
2016 |
The Two Faces of Fractionated Photodynamic Therapy: Increasing Efficacy With Light Fractionation or Adjuvant Use of Fractional Laser Technology. |
ALA, MAL, PDT |
| 78 |
2016 |
Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites. |
MMS |
| 79 |
2015 |
Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. |
BT |
| 80 |
2015 |
Cutaneous malignancy of the head and neck. |
--- |
| 81 |
2015 |
Dual S-100-AE1/3 Immunohistochemistry to Detect Perineural Invasion in Nonmelanoma Skin Cancers. |
IHC, PNI |
| 82 |
2015 |
Giant neglected squamous cell carcinoma of the skin. |
cSCC, ECT |
| 83 |
2015 |
Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience. |
RCM |
| 84 |
2015 |
Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. |
AUC, MMS |
| 85 |
2015 |
mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review. |
mTHPC, PDT |
| 86 |
2015 |
Multiple skin cancers in a single patient: Multiple pigmented Bowen's disease, giant basal cell carcinoma, squamous cell carcinoma. |
BCC, BD |
| 87 |
2015 |
Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study. |
AKs, IMIQ, MAL, PDT |
| 88 |
2015 |
Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis. |
GPA, SIRs |
| 89 |
2015 |
Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients. |
mTOR, SCCs, UV |
| 90 |
2015 |
Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models. |
ALA, BCC, PDT, SCC |
| 91 |
2014 |
Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. |
CIs, IBD |
| 92 |
2014 |
Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention. |
COX-2 |
| 93 |
2014 |
Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab. |
cSCCs |
| 94 |
2014 |
Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes. |
beta HPVs, EV |
| 95 |
2014 |
Histopathological evaluation of non-melanoma skin cancer. |
BCC, SCC |
| 96 |
2014 |
Immunohistochemical Analysis of Cyclooxygenase-2 in Non-Melanocytic Skin Cancer: Correlation With Morphological Subtype and Histologic Grade. |
BCCs, COX-2, SCCs |
| 97 |
2014 |
Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. |
BCC, SCC, UVR |
| 98 |
2014 |
Location of nonmelanoma skin cancers in patients after kidney transplantation. |
--- |
| 99 |
2014 |
Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma. |
ET, HU, MPNs, SCC |
| 100 |
2013 |
Chemoprevention of nonmelanoma skin cancer. |
SCC |
|
A Search Service for Abbreviation / Long Form
